Abstract 15913: Novel Dual MTOR Inhibitors/AMPK Activators Attenuate Doxorubicin-Induced Cardiotoxicity
2019
Background: Doxorubicin (DOX) is among the most widely used and highly efficacious anticancer drugs for the treatment of breast cancer, however, its therapeutic application is limited by its life-t...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI